Trial
NCT05760781
To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Collaborators
Beijing Sanuo Jiayi Biotechnology Co. LTD
Condition
Chronic Hepatitis b
Intervention
STSG-0002 Injection
Why stopped
The preliminary effectiveness data observed at present did not meet the expectations, the benefit of the subjects receiving the experimental drug was limited.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-19